April 14, 2026 03:30 ET | Source: Asgard Therapeutics Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s…
Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support…
MOUNTAIN VIEW, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Commure today announced Commure Dictation, a speech-to-cursor extension that brings its…
Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue…
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing…
New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug developmentHUNTSVILLE, Ala. and HAMBURG, Germany,…
MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical…
SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced it has…
March 11, 2026 19:21 ET | Source: Mesoblast Limited NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the…